Social phobia and premature ejaculation: A case-control study

Jean Tignol, Corinne Martin-Guehl, Bruno Aouizerate, Denis Grabot, Marc Auriacombe
Depress. Anxiety. 2006-01-01; 23(3): 153-157
DOI: 10.1002/da.20159

Lire sur PubMed

1. Depress Anxiety. 2006;23(3):153-7.

Social phobia and premature ejaculation: a case-control study.

Tignol J(1), Martin-Guehl C, Aouizerate B, Grabot D, Auriacombe M.

Author information:
(1)Department of Psychiatry, University Victor Segalen School of Medicine and
Charles Perrens Hospital, Bordeaux Cedex, France.

In a previous case-control study, we found marked differences between a group of
patients with male sexual disorders and a control group without any sexual
disorder regarding the percentage of social phobia (SP) in each group. On this
basis, our aim in this study was to test the hypothesis that premature
ejaculation (PE) as a specific sexual disorder and SP might be strongly related,
by comparing subjects with PE to a control group without any sexual disorder
regarding the diagnosis of SP. Subjects with PE were recruited at private
practice sexology settings in France. Control subjects were recruited among
inpatients in a surgical ward. Diagnosis of SP was made with the Composite
International Diagnostic Interview. Diagnosis of PE was clinician-rated according
to DSM-IV criteria. Eighty-five subjects with PE only were compared to 93 control
subjects without any sexual disorder. Forty (47%) subjects with PE versus 8 (9%)
controls were diagnosed with SP (chi(2)=3.35, df=1, P=.001). Logistical analysis
showed that SP and PE were strongly associated (odds ratio=10.97, 95%
CI=4.49-26.06; chi(2)=28.28, df=1, P=.0001). This study is the first to show a
clear relationship between SP and PE. Although requiring confirmation by further
studies, this finding has immediate clinical consequences given that SP and PE
can be treated by the same medication, a selective serotonin-reuptake inhibitor
(SSRI). Moreover, since SP is a likely risk factor for PE, this might argue for
preventive action on both disorders in children.

DOI: 10.1002/da.20159
PMID: 16502416 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus